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Abstract
Background: Cathepsin-like enzymes have been identified as potential targets for drug or vaccine development in many
parasites, as their functions appear to be essential in a variety of important biological processes within the host, such as
molting, cuticle remodeling, embryogenesis, feeding and immune evasion. Functional analysis of Caenorhabditis elegans
cathepsin L (Ce-cpl-1) and cathepsin Z (Ce-cpz-1) has established that both genes are required for early embryogenesis, with
Ce-cpl-1 having a role in regulating in part the processing of yolk proteins. Ce-cpz-1 also has an important role during
molting.
Methods and Findings: RNA interference assays have allowed us to verify whether the functions of the orthologous filarial
genes in Brugia malayi adult female worms are similar. Treatment of B. malayi adult female worms with Bm-cpl-1, Bm-cpl-5,
which belong to group Ia of the filarial cpl gene family, or Bm-cpz-1 dsRNA resulted in decreased numbers of secreted
microfilariae in vitro. In addition, analysis of the intrauterine progeny of the Bm-cpl-5 or Bm-cpl Pro dsRNA- and siRNA-
treated worms revealed a clear disruption in the process of embryogenesis resulting in structural abnormalities in embryos
and a varied differential development of embryonic stages.
Conclusions: Our studies suggest that these filarial cathepsin-like cysteine proteases are likely to be functional orthologs of
the C. elegans genes. This functional conservation may thus allow for a more thorough investigation of their distinct
functions and their development as potential drug targets.
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Introduction
Human lymphatic filariasis (LF), caused by the filarial parasites
Brugia malayi, Brugia timori and Wuchereria bancrofti, infects 120
million people worldwide, of which 40 million people show
chronic disease symptoms (www.globalnetwork.org) [1]. The
disease is estimated to be responsible for 5.5 million DALYs,
and is the second leading cause of permanent and long-term
disability worldwide [2]. A further one billion people (18% of the
world’s population) are at risk of infection (www.globalnetwork.
org).
The Global Programme to Eliminate Lymphatic Filariasis
(GPELF) aims to use mass drug administration (MDA) to interrupt
transmission and to reduce morbidity, with annual doses of a
multi-drug regimen for at least five years (www.filariasis.org) [3].
The African Programme for Onchocerciasis Control aims to
establish by 2010 community-based sustainable ivermectin
treatments of 50 million people in 19 African countries having
meso- and hyper-endemicity (www.who.int/apoc/en/). However,
it appears unlikely that any of these MDA regimens will be
sufficient to eliminate LF or onchocerciasis in all endemic areas
[2]. Numerous technical challenges threaten the success of these
eradication programs [2,4], including incomplete efficacy of
available drugs against adult filarial worms [5,6], severe drug
toxicity in people with heavy loiasis infections [3], and the risk that
filarial worms will develop resistance to the drugs available for
MDA [7,8]. Ivermectin (IVM) resistance has been reported
worldwide in several other parasitic nematodes [9].
The emergence of drug resistant strains of the O. volvulus parasite
was initially suggested by reports of patients with onchocerciasis
who failed to respond to IVM treatment [10,11] and a recent
report from Ghana has provided the first direct proof of IVM
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associated IVM resistance with genetic markers (reviewed in [13]),
while a recent, more extensive study using worms taken from
individuals before and after repeated IVM treatments, has
demonstrated that IVM causes genetic selection on O. volvulus
[14]. At present there are no alternative drugs for IVM for use in
the onchocerciasis MDA programs that can reduce Mf or kill adult
worms and no vaccines are available [15]. Vaccines that decrease
transmission would complement MDA programs and may be
necessary for complete elimination [13]. Notably, antibiotic
treatment targeting Wolbachia endosymbionts of filarial nematodes
is emerging as an alternative drug treatment for filariasis.
Doxycycline treatment has been shown to result in an almost
complete loss of Mf and macrofilaricidal effects in LF and in
sterilization of adult worms and macrofilaricidal effects in O.
volvulus (reviewed in [16,17]). However, the period of treatment
with doxycycline at present (between 4–8 weeks) is not applicable
to mass treatment strategies, due to both the logistical difficulties
and contra-indication in children under eight and pregnant
women [16,17], as a result antibiotic treatment regimens require
further refinement.
Therefore, a major priority has to be the identification of new
drugs with strong activity against adult filarial worms (macro-
filaricidal) which have new classes of chemistry, new molecular
targets, and novel modes of action. Recent breakthroughs in
genomics and chemistry make macrofilaricidal drug development
more feasible, and accordingly a high priority goal with the
WHO/TDR and the Bill & Melinda Gates Foundation
[8,18,19,20,21].
RNA interference (RNAi) was first described in Caenorhabditis
elegans where it was shown to spread systemically throughout the
whole organism [22] and is widely used to identify gene function
and has been developed for high-throughput genomics [23,24,25].
This powerful reverse genetics mechanism thus provides an
invaluable tool which could be transferred to gene function
studies and novel drug discovery in filarial nematodes. Moreover,
it potentially provides an unprecedented opportunity to identify
pre-validated drug targets after efficient mining of nematode
genomic databases and RNAi genome wide C. elegans databases.
[26,27,28,29]. RNAi has been successfully demonstrated in a
number of parasitic nematodes (reviewed in [30,31]), including
filarial nematodes [32,33,34,35,36]. However, although RNAi has
been demonstrated in parasitic nematodes, its application as a tool
for high-throughput functional genomic screening for identifica-
tion of essential parasite genes has not yet been achieved due to
variable success in transferring the technology from C. elegans to
parasitic nematodes and problems with inconsistent results and
poor reproducibility [30,37].
While a wide range of target genes have been screened using
RNAi in parasitic nematodes, only a small number of these genes
have been selected due to their potential as drug targets [31].
Filarial proteases have been recognized as potential drug targets
[33,38]. RNAi targeting the cathepsin L- and Z-like cysteine
proteases (CPL & CPZ respectively) has clearly validated their
essential role during O. volvulus L3 molting [33]. The function(s) of
CPLs in filarial nematodes during embryogenesis, however, was
only predicted indirectly by immunoelectron microscopy (IEM)
[39,40], while detailed studies of the CPLs in C. elegans [40,41]
have provided more direct proof of their function in the free living
nematodes. However, their predicted essential function during
development may not always be conserved in both filarial
nematodes and C. elegans, as has been shown for the roles of
CPL and CPZ in the molting of O. volvulus and C. elegans [33].
Therefore it would be beneficial to be able to directly and reliably
assess their essential function(s) using RNAi technology in filarial
adult worms, in particular during embryogenesis. Here we
demonstrate the use of double-stranded RNA (dsRNA)-mediated
silencing to study the possible function of several of thecathepsin-like
enzymes in B. malayi.
Materials and Methods
Parasites
Adult female B. malayi, collected from the peritoneal cavities of
infected jirds (Meriones unguiculatus) at day 80–85 post-infection,
were kindly provided by the NIAID/NIH Filariasis Research
Reagent Repository Center (Athens, GA; www.filariasiscenter.
org). Worms were washed once in normal culture medium (CM;
RPMI-1640, 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-glutamine, 2.5 mg/ml amphotericin B, and 25 mM
HEPES (Sigma, St Louis, MO)) preheated to 37uC. Individual
worms were transferred into 1 ml of normal CM in 48 well culture
plates (Corning Inc. Life Sciences, Lowell, MA) and cultured
overnight at 37uC under 5% CO2 to ensure the absence of any
contaminating microorganisms. Release of Mf was measured after
overnight culture. Viable and motile worms, which were secreting
motile Mf and were in the middle of the Mf release distribution,
were selected for RNAi treatment.
Cloning of target B. malayi gene fragments for in vitro
transcription
The GenBank accession numbers of the targeted B. malayi
cathepsin-like cysteine protease (CP) genes and the gene-specific
primers used to amplify the target genes are listed in Table 1.
Fragments corresponding to cDNA regions of the B. malayi
cathepsin-like genes; Bm-cpl-1, Bm-cpl-5, and Bm-cpz, were
amplified by PCR using gene-specific primers designed against
the published sequences [39] (Table 1). A smaller fragment
corresponding to pro-region of the Bm-cpl genes (Bm-cpl Pro),
designed to knock-down the three B. malayi cpl genes; Bm-cpl-1, Bm-
cpl-4 and Bm-cpl-5 (group Ia of the filarial cathepsin L-like cysteine
protease gene family [39]), which have identical pro-region
sequences, was amplified using gene-specific primers (Table 1).
Author Summary
Filarial nematodes are an important group of human
pathogens, causing lymphatic filariasis and onchocerciasis,
and infecting around 150 million people throughout the
tropics with more than 1.5 billion at risk of infection.
Control of filariasis currently relies on mass drug admin-
istration (MDA) programs using drugs which principally
target the microfilarial life-cycle stage. These control
programs are facing major challenges, including the
absence of a drug with macrofilaricidal or permanent
sterilizing activity, and the possibility of the development
of drug-resistance against the drugs available. Cysteine
proteases are essential enzymes which play important
roles in a wide range of cellular processes, and the
cathepsin-like cysteine proteases have been identified as
potential targets for drug or vaccine development in many
parasites. Here we have studied the function of several of
the cathepsin-like enzymes in the filarial nematode, B.
malayi, and demonstrate that these cysteine proteases are
involved in the development of embryos, show similar
functions to their counterparts in C. elegans, and therefore,
provide an important target for future drug development
targeted to eliminate filariasis.
RNAi of B. malayi Cysteine Protease Genes
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of the O. volvulus cpz gene sequence Ov-cpz-int2 (position 621-1132,
GenBank accession no. AY591516), was amplified as a negative
control as described previously [33]. The sequence was checked
for putative microRNAs (miRNA) using the miRBase database
(http://microrna.sanger.ac.uk/sequences/index.shtml) and by fold-
ing it using Mfold (http://frontend.bioinfo.rpi.edu/applications/
mfold/cgi-bin/rna-form1.cgi). These analyses were used to
determine if Ov-cpz-int2 contains any strong hairpins with a delta
G#225 kcal/mol which might indicate a unique miRNA which
could potentially initiate miRNA silencing at the translational level
[42,43]. Both methods have shown that the Ov-cpz-int2 sequence
has no miRNA sequences (C. Poole&L. McReynolds, New
England Biolabs, personal communication) that could have
induced silencing of the target gene using a different pathway to
dsRNA-induced silencing. E. coli b-lactamase (Ec-bla) dsRNA
(GenBank accession no. NC_010862, position 24517-24770) [31]
was also used as a negative control. The PCR fragments were then
sub-cloned into pCR4-TOPO vector (Invitrogen, Carlsbad, CA)
or pBluescript SK vector (Stratagene, La Jolla, CA) according to
the manufacturer’s instructions. Clones were confirmed by
sequencing both strands. Plasmids were then purified using the
Rapid Plasmid Miniprep System (Marligen Biosciences Inc.,
Ijamsville, MD) and were used as templates for RNA in vitro
transcription.
Production of dsRNA, siRNA and Cy3-labeled RNAs
For RNA transcription, cDNA template from the purified
plasmid was amplified with M13 forward and M13 reverse
primers (Invitrogen) and then used with either T3 and T7 RNA
polymerase for the single-stranded sense or antisense RNA
synthesis using the MEGAscript high yield transcription kit
(Ambion Inc., Austin, TX). Large quantities of dsRNA were
prepared as previously described [44]. Integrity of dsRNA was
checked by standard agarose gel electrophoresis. The final size (bp)
of dsRNA is approximately 120 bp larger than the amplified gene-
specific fragment due to vector linker sequence between the T3
and T7 priming sites and inserted gene fragment. Short-interfering
RNA (siRNA) corresponding to the specific target was produced
by digesting transcribed dsRNA with RNase III (Ambion)
according to the manufacturer’s instructions. Undigested and
partially RNaseIII digested material was removed using a siRNA
purification unit (Ambion). The siRNA was quantified by
measuring absorbance and the concentration calculated according
to the manufacturer’s instructions.
The penetration of both dsRNA and siRNA into adult female B.
malayi was followed using fluorescently-labeled RNA. dsRNA and
siRNA were fluorescently labeled with cyber red, Cy3 (Cy3-RNA),
using the Silencer siRNA labeling kit (Ambion) according to the
manufacturer’s instructions. B. malayi adult female worms, in
groups of 4, were soaked in normal CM containing Cy3-RNA
(0.01 mg/ml) for 24–72 h. Fluorescence was visualized using a
Zeiss Axiovert fluorescence microscope using the rhodamine filter
set, using emission 590 nm.
RNA interference (RNAi) treatment of B. malayi adult
females
RNAi treatment of B. malayi adult females was carried out by
soaking with dsRNA or siRNA. dsRNA preparations were
dialyzed for 3 h in D-tube Maxi dialysis tubes, 12–14 kDa cut-
off (Novagen, EMD Biosciences, Inc., Madison, WI), at 37uC
under 5% CO2, against normal culture medium before incubation
with B. malayi adult female worms.
Following 24 h culture in normal culture medium at 37uCi na
5% CO2 incubator, viable and motile worms were transferred into
48-well plates in groups of 3–4 adult females per well. Each group
was cultured for upto 3 d in 1 ml of normal CM containing 1.5–
2 mg/ml dsRNA or 5 mM (45 mg/ml) siRNA, with a daily change
of media containing dsRNA. Following RNAi treatment, worms
were transferred to normal CM containing 10% heat-inactivated
Table 1. GenBank accession numbers, and primer sequences and positions used for gene specific dsRNA production and real-time
RT-PCR (qRT-PCR) with the resulting fragment size.
Gene target Accession number Primer name Position Primers (59-39) Gene specific primer product
dsRNA production
Bm-cpl-1 AF331035 Bm-cpl-1F 548 CCAAGTTCAGTTGATTGG 642 bp
Bm-cpl-1R 1189 GATGGGAAATGAACCCATCG
Bm-cpl-5 AY533167 Bm-cpl-5F 550 CTGCCAGATCAAGTTGAC 648 bp
Bm-cpl-5R 1197 CGGGAAATGAAGCCATAG
Bm-cpl Pro AY533167 Bm-cpl Pro F 117 CAATATGACGAGACTTGCGT 334 bp
Bm-cpl Pro R 450 GACCATAAATTCTTCATCGG
Bm-cpz AY533170 Bm-cpz F 200 CGAAGACTTACCTATAGC 289 bp
Bm-cpz R 488 TTTCGTGTGGTATGCCAAC
Ov-cpz-int2 AY591516 Int2 F 621 TTCCTTTTCGGAGAATTAGC 512 bp
Int2 R 1132 TATGGAAAAAGATCGAAATT
qRT-PCR
Bm-tub-1 AY705382 Bm-tubF 173 AATATGTGCCACGAGCAGTC 307 bp
Bm-tubR 479 GGATACTCCTCACGAATTT
Bm-cpl AY533167 Bm-cpl RTF 100 GACAAAGATTACAAACAGGGC 381 bp
Bm-cpl RTR 480 TGATTGGGCAGTCGAAGTC
doi:10.1371/journal.pntd.0000377.t001
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change of media. Every 24 h throughout the experiment adult
female phenotypes were monitored microscopically, and the
number and the phenotype of the secreted progeny, microfilariae
(Mf), pre-microfilariae (p-mf), embryos and eggs, were recorded.
To compare progeny release after RNAi treatment, release was
expressed as a reduction in release in comparison to the release in
the dsRNA-free medium control group. At the end of the
experiment (2 d after RNAi treatment) worms were collected for
either embrograms, where intrauterine progeny were recovered
from individual female worms, or RNA extraction for quantitative
real-time PCR (qRT-PCR) analysis. Worms were gently homog-
enized in 0.5 ml normal culture medium for 2–3 min, and the
resulting suspension was examined microscopically to determine
the relative proportions of progeny at different stages of
development.
RNAi treatment with dsRNA was repeated using dialysis tubes
instead of 48-well plates, as previously demonstrated by Abooba-
ker et al (2003) [34] using a modified protocol. Worms were
incubated in dsRNA for 4 d in dialysis tubes (D-tube Maxi dialysis
tubes, 12–14 kDa cut-off) and dialyzed against normal culture
medium, which allowed for a longer incubation time in dsRNA
and no further handling of the worms during the incubation
period.
Bm-cpl-1, Bm-cpl-5, Bm-cpl Pro and Bm-cpz dsRNAs were used as
the test RNAi treatments, with negative controls being either
culture medium containing RNA storage buffer (medium control),
dsRNA corresponding to an O. volvulus intronic sequence Ov-cpz-
int2 or E. coli b-lactamase (Ec-bla) (negative control). Each
experiment was repeated at least three times.
Real-time RT-PCR
Loss of specific transcripts following RNAi treatment were
examined by real-time quantitative RT-PCR (qRT-PCR). Primers
used were designed to prevent re-amplification from dsRNA
(Table 1) and to amplify all three of the B. malayi filarial group Ia
cathepsin L-like cysteine protease genes; Bm-cpl-1, Bm-cpl-4 and
Bm-cpl-5 (Bm-cpl). Our initial attempts to design dsRNA-mediated
silencing confirmation primers to distinguish the three Bm-cpl
genes were unsuccessful; Bm-cpl-4 and Bm-cpl-5 are 94% identical,
while Bm-cpl-1 is 83% identical to Bm-cpl-4 and Bm-cpl-5.
Moreover, because of the strong similarity, we assumed that
dsRNA-mediated silencing with Bm-cpl-5 dsRNA will cross-target
also Bm-cpl-4 and Bm-cpl-1. However, it will not be able to cross-
target the other five phylogenetically distinct cpl genes that belong
to group Ic [39]. This was further established by comparing the
predicted siRNA in these three transcripts to those of group Ic
using the Protein Lounge siRNA Database (www.proteinlounge.
com); none of which were similar to those predicted for Bm-cpl-1,
-4 and -5. B. malayi b-tubulin (Bm-tub-1; GenBank accession
no. AY705382) was used as the endogenous control gene. At the
end of the experiment (2 d after RNAi treatment), groups of four
adult female worms were removed from culture, washed in PBS,
and flash frozen in liquid N2. Frozen worms were homogenized in
Trizol reagent (Invitrogen) and RNA was extracted as previously
described [40]. First strand cDNA was generated using the
SuperScript III first strand cDNA synthesis kit (Invitrogen) and
priming with oligo(dT)20. The specific cDNA fragments were then
amplified by real-time PCR using QuantiTect SYBR Green PCR
kit (Qiagen Inc, Valencia, CA) and the ABI Prism 7700 Sequence
Detection System (Applied Biosystems, Foster City, CA). The
PCR conditions used were 50uC for 2 min, 95uC for 15 min,
followed by 40 cycles of 94uC for 15 s, 52–58uC for 30 s, 72uC for
30 s. The relative amount of test amplicon in each experiment was
determined by using the comparative CT method normalizing
against the endogenous control gene (Bm-tub-1), as described in the
ABI PRISM Sequence Detection System User Bulletin No2
(Applied Biosystems). The value of the medium control group was
set to 100% and the relative reduction of the RNAi treated groups
was calculated and expressed as a percentage reduction in
comparison to the control group.
Statistical Analysis
Comparison between the groups in RNA interference experi-
ments were analyzed using the two-tailed non-parametric Mann-
Whitney U-test. A P value of ,0.05 was considered statistically
significant.
Results
dsRNA-mediated silencing of the B. malayi cathepsin-like
cysteine protease genes, Bm-cpl-1, Bm-cpl-5, and Bm-cpz
results in the reduction of Mf secretion in vitro
To determine the possible function(s) of the B. malayi cathepsin-
like cysteine protease genes during embryogenesis of B. malayi,
RNAi was carried out to selectively interfere with Bm cathepsin-
like cysteine protease gene expression; Bm-cpz or Bm-cpl.
Microfilarial release was determined prior to RNAi treatment to
provide a baseline reading and shows that grouped worms were
evenly distributed in terms of Mf release (Fig. 1A). Daily
microfilarial release was determined from control and RNAi
treated adult female worms which were cultured for 18 h in the
presence of gene-specific dsRNA (2 mg/ml) and then cultured for
an additional 48 h in dsRNA-free culture medium. In comparison
to the control worms and the worms treated with a negative
control dsRNA (Ov-cpz-int2), adult worms treated with dsRNAs
corresponding to the cathepsin-like cysteine protease genes, Bm-
cpl-1, Bm-cpl-5 and Bm-cpz, all showed a reduction in the release of
Mf into the culture medium (Fig. 1B & C). This reduction in the
secretion of Mf corresponded to a 71.4% (Bm-cpl-1), 92.8% (Bm-
cpl-5) and 61.3% (Bm-cpz), inhibition (average) of Mf release 48 h
after RNAi treatment. The reduction in the release of Mf after
treatment with Bm-cpl-5 dsRNA was significantly different from
both the control worms (P=0.026; 48 h after RNAi) and the
negative control (Ov-cpz-int2) treated worms (P=0.002 and 0.041;
24 h and 48 h after RNAi respectively) (Fig. 1). This demonstrates
a persistent effect of dsRNA-mediated silencing as worms had
been cultured in dsRNA-free medium for a further 24–48 h
following RNAi treatment. As we saw the most significant
reductions in the release of Mf after treatment with dsRNA
corresponding to Bm-cpl-5 (Fig. 1B & C) we decided to focus on
optimization of the RNAi technique and analyzing the effect on
embryogenesis using dsRNA corresponding to Bm-cpl-5 and to the
identical pro-region of Bm-cpl-1, Bm-cpl-4 and Bm-cpl-5; Bm-cpl Pro,
which was designed to target all three Bm-cpl transcripts.
Uptake of Cy3-labeled RNAs by adult female B. malayi
In order to optimize and utilize the RNAi soaking technique in
B. malayi to target the cathepsin-like cysteine protease genes it was
important to demonstrate uptake of the in vitro transcribed dsRNA
and siRNA by adult female B. malayi. FITC-labeled Bm-tub-1
dsRNA (approx. 300 bp) has previously been shown to be taken
up successfully by adult female B. malayi after soaking for 18 h with
0.08 mg/ml dsRNA [34].
Cy3-labeled Bm-cpl RNAs, both dsRNA and siRNA, were taken
up by adult worms in vitro after soaking for 24–72 h at 0.01 mg/ml
(Fig. 2). Uptake of Cy3-labeled RNA was clearly seen after 24 h
incubation with Cy3-labeled RNAs corresponding to a fragment of
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www.plosntds.org 4 February 2009 | Volume 3 | Issue 2 | e377Figure 1. dsRNA-mediated silencing of the B. malayi cathepsin-like genes, Bm-cpl-1, Bm-cpl-5, and Bm-cpz leads to a reduction in
microfilaria release from B. malayi in vitro. Following 24 h culture in normal culture medium, two groups of 3 female B. malayi worms were
soaked for 18 h in 2 mg/ml gene-specific dsRNA (Bm-cpl-1, Bm-cpl-5, Bm-cpz, Ov-cpz-Int2) or medium alone (control). Following dsRNA treatment,
individual worms were transferred to dsRNA-free medium and cultured for an additional 48 h. Released microfilariae were collected and counted
daily. Results are expressed as Mf release before RNAi treatment (A), 24 h (B) and 48 h (C) after treatment. Each graph represents one experiment
which is representative of at least 3 separate experiments. P values denote a significant difference between dsRNA-treated worms and either
untreated medium controls or negative control (Ov-cpz-Int2) (Mann-Whitney U-test).
doi:10.1371/journal.pntd.0000377.g001
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esophagus and intestine after 24 h and in the cuticular and
hypodermal regions after 48 h and 72 h (Fig. 2A). Uptake of the
Cy3-labeled RNAs appeared to be affected by the size of the
dsRNA. While the dsRNA Bm-cpl-5 fragment (approx. 800 bp)
was taken up by the adult worms and was seen in the hypodermal
regions only after 48 h, the siRNA appeared in these regions
earlier and was clearly already seen after 24 h (Fig. 2B). In
addition, a smaller dsRNA corresponding to the pro-region of Bm-
cpl; Bm-cpl Pro (approx. 400 bp) gave a more intense and diffuse
uptake staining pattern after 72 h when compared to the uptake of
the larger Bm-cpl-5 fragment (Fig. 2C). The smaller Bm-cpl Pro
Cy3-labeled dsRNA and the Cy3-labeled siRNAs were also found
along the length of the uterus. It is important to note that while the
dsRNAs were added at the same concentration (wt/vol), they have
different molarities due to their different lengths, Bm-cpl-5; approx.
800 bp, 0.019 mM, Bm-cpl Pro; approx. 400 bp, 0.038 mM, siRNA;
approx 13.5 bp, 1.1 mM. This uptake was consistent in all worms
examined.
We also examined whether the use of a lipid carrier (lipofectin)
could improve the uptake of dsRNA. Lipofectin was not toxic to B.
malayi adult female worms, however, lipofectin mixed with Bm-cpl-
5 dsRNA did not improve the penetration of dsRNA (data not
shown).
dsRNA-mediated silencing of B. malayi cpl-5 and the pro-
region of Bm-cpl results in the inhibition of Mf secretion
in vitro, death of Mf, and changes in intrauterine progeny
potentially resulting from a specific change in Bm-cpl
transcript level
We next examined in more detail the effect of RNAi selectively
carried out to interfere with Bm-cpl gene expression using both Bm-
cpl-5 and Bm-cpl Pro. Microfilarial release was determined daily
from worms cultured in the presence of gene-specific dsRNA
(1.5 mg/ml, Bm-cpl-5; 2.82 mM, Bm-cpl Pro; 5.63 mM) or their
corresponding siRNA (5 mM) for 3 d, and then cultured for a
further 2 d in dsRNA-free culture medium. In comparison to the
control worms, adult worms treated with dsRNA or siRNA
corresponding to the Bm-cpl genes showed a persistent and
significant reduction in the release of Mf into the culture medium
after 1, 3 and 5 days (P,0.05 for all) (Fig. 3). Reduction in Mf
release after treatment with Bm-cpl-5 dsRNA was equivalent to
that shown in Fig. 1. Although treatment with the negative control
dsRNA, Ov-cpz-int2, did result in a reduction in the release of Mf
this reduction was not significantly different from the medium
control (P.0.05) (Fig. 3). Reduction in the release of Mf was seen
most rapidly after treatment with Bm-cpl-5 dsRNA, however, by
Figure 2. Demonstration of uptake of Cy3-labeled dsRNAs or siRNA by B. malayi. Adult female B. malayi (2 groups of 4 worms) were soaked
in normal culture medium containing Cy3-dsRNA (0.01 mg/ml) for 24–72 h. Uptake was examined for Bm-cpl-5 dsRNA (,800 bp) (A), Bm-cpl-5 siRNA
(B), Bm-cpl Pro dsRNA (,400 bp) (C) and Bm-cpl Pro siRNA (D). Fluorescence was visualized using a Zeiss Axiovert fluorescence microscope using the
rhodamine filter set, using emission 590 nm.
doi:10.1371/journal.pntd.0000377.g002
Figure 3. dsRNA treatment of adult female B. malayi with Bm-
cpl-5 and the pro-region of Bm-cpl (Bm-cpl Pro) leads to an
inhibition of B. malayi microfilaria secretion in vitro. 8 female
worms (2 groups of 4 worms) were treated for 3 d with 1.5 mg/ml
gene-specific dsRNA or 5 mM siRNA, corresponding to Bm-cpl-5 or Bm-
cpl-Pro. Worms were then cultured for a further 2 d in culture medium
alone. Mf secretion was recorded daily and release expressed as a
reduction in release in comparison to the dsRNA-free medium control
group on day 1 (open bars), day 3 (hashed bars), and day 5 (closed
bars). Data represents one representative experiment from at least 3
separate experiments.
doi:10.1371/journal.pntd.0000377.g003
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equivalent reductions in Mf release. Importantly, reductions in Mf
release were also seen after treatment with siRNA corresponding
to the Bm-cpl-5 and Bm-cpl Pro genes (Fig. 3). We also noted that in
the groups treated with either Bm-cpl-5 or Bm-cpl Pro dsRNA the
majority of Mf which were released from day 1 onwards were
immotile and granulated (approx. 90–95%) suggesting that the Mf
were dead (data not shown).
RNAi treatment with Bm-cpl-5 and Bm-cpl Pro genes had
dramatic effects on intrauterine embryogram profiles (Fig. 4).
Intrauterine progeny were examined 2 d after RNAi treatment
and expressed as the relative proportions of progeny at different
stages of development; eggs, developing embryos, pre-microfilariae
(pre-Mf) and Mf. In comparison to the percentage of intrauterine
pre-Mf in both the medium control (21.2%) and the negative
control, Ov-cpz-int2 (22.1%) adult female worms treated with Bm-
cpl-5 and Bm-cpl Pro dsRNA or siRNA showed significant
reductions in pre-microfilariae (pre-Mf); Bm-cpl-5 dsRNA; 6.8%
(Control; P=0.002, Ov-cpz-int2; P=0.004), Bm-cpl-5 siRNA;
13.2% (Control; P=0.0037, Ov-cpz-int2; ns), Bm-cpl Pro dsRNA;
9.0% (Control; P=0.0011, Ov-cpz-int2; P=0.028), and Bm-cpl Pro
siRNA; 11.6% (Control; P=0.0003, Ov-cpz-int2; P=0.016). While
the numbers of pre-Mf were reduced, the percentage of embryos
within the uterine progeny were significantly increased in
comparison to medium control (49.1%) and the negative control,
Ov-cpz-int2 (51.3%); Bm-cpl-5 dsRNA; 64.2% (Control; P=0.002,
Ov-cpz-int2; P=0.048), Bm-cpl-5 siRNA; 64.5% (Control;
P=0.0037, Ov-cpz-int2; P=0.042), Bm-cpl Pro dsRNA; 64.0%
(Control; P=0.0011, Ov-cpz-int2; P=0.028), and Bm-cpl Pro
siRNA; 60.2% (Control; P=0.0003, Ov-cpz-int2; ns). No changes
were observed in the proportions of Mf or eggs within the uterus.
Phenotypic changes and structural abnormalities in developing
embryos were also observed following RNAi treatment (Fig. 5).
Treatment with either Bm-cpl-5 dsRNA (Fig. 5C) or Bm-cpl Pro
dsRNA (Fig. 5D) resulted in malformed intrauterine embryos in
comparison to both the medium control (Fig. 5A) and negative
control (Fig. 5B). Embryos from treated worms appeared to be not
fully developed within the eggshell, leading to space between the
embryo and eggshell. Effects on embryonic viability were also
observed following RNAi treatment with Bm-cpl suggesting that
the eggs and embryos released from Bm-cpl treated B. malayi were
less viable (18–22% viable) than those from controls as
demonstrated by MTT viability staining [45] (data not shown).
RNAi treatment was repeated using dialysis tubes instead of the
culture plate system. Worms were incubated in dsRNA for 4 d in
dialysis tubes and dialyzed against normal culture medium, which
allowed for a longer incubation time in dsRNA with the total
amount of dsRNA required being much less. RNAi treatment
targeting the B. malayi cathepsin-like cysteine protease group Ia
genes using dialysis tubes resulted in similar phenotypic effects to
those seen in the culture plate system (data not shown). RNAi in
dialysis tubes has the potential to facilitate higher-throughput
RNAi screens for selected genes.
RNAi treatment targeting Bm-cpl-5 and Bm-cpl Pro using both
dsRNA and siRNA resulted in a specific reduction in Bm-cpl
transcript level (Fig. 6). Analysis by qRT-PCR on RNA isolated
from the RNAi treated worms, which had identical phenotypes to
those shown in Figs. 1&3, showed that the Bm-cpl transcript levels
were reduced by 51.0% in Bm-cpl-5 dsRNA treated worms and by
48.9% in the siRNA treated worms, these reductions were
significantly different from both the medium control (dsRNA;
P=0.0006, siRNA; P,0.0001) and the negative control (dsRNA;
P=0.0033, siRNA; P,0.0001). The Bm-cpl transcript levels were
also reduced in Bm-cpl Pro treated worms; 66.5% and 37.4% in
dsRNA and siRNA treated worms respectively, with significant
differences from both the medium control (dsRNA; P=0.0003,
siRNA; P=0.002) and the negative control (dsRNA; P=0.0016,
siRNA; P=0.0082). The percent reduction was normalized using
a tubulin (Bm-tub-1) transcript. In comparison, the Bm-cpl-3 (89%
identical to Bm-cpl-2 and -7) and Bm-cpl-6 transcripts that belong to
the Ic subgroup of the B. malayi cysteine protease protein family
were not reduced in the Bm-cpl Pro treated worms (data not
shown). These data demonstrate that the inhibition of Mf secretion
in vitro, death of Mf, and changes in intrauterine progeny following
dsRNA-mediated silencing is likely associated with reductions in
the Bm-cpl gene specific transcript levels belonging to group Ia.
Discussion
Cysteine proteases play important roles in both intracellular and
extracellular processes which are important in both development
and survival. Cathepsin-like enzymes have been identified as
potential targets for drug or vaccine development in many
parasites, including filarial nematodes [33,38], due to as their
potential essential roles in feeding [46,47,48], molting [33,49],
embryogenesis [40,44] and immune functions [50] (reviewed in
[51]). Here we describe the use of RNAi techniques in B. malayi
adult females to directly assess the function(s) of the cysteine
Figure 4. Embryogenesis effects following treatment of adult
female B. malayi with dsRNA or siRNA. Intrauterine progeny from
individual female worms (groups of four adult worms) were examined
2 d after dsRNA treatment and expressed as the relative proportions of
progeny at different stages of development. Data represents one
representative experiment from at least 3 separate experiments.
doi:10.1371/journal.pntd.0000377.g004
Figure 5. Treatment of adult female B. malayi with Bm-cpl-1, Bm-
cpl-5, and Bm-cpz dsRNAs leads to phenotypic changes in
developing embryos. Intrauterine progeny from individual female
worms were examined 2 d after treatment with medium control (A), Ov-
cpz-Int2 control dsRNA (B), Bm-cpl-5 dsRNA (C) and Bm-cpl Pro dsRNA
(D).
doi:10.1371/journal.pntd.0000377.g005
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Bm-CPL protein families.
In filarial nematodes the gene family of group Ia cathepsin L-
like protease enzymes (Bm-cpl: Bm-cpl-1, Bm-cpl-4 and Bm-cpl-5) has
been shown to be associated with larval molting and remodeling of
the cuticle and eggshell [39]. Antibodies raised to Ov-CPL-1 (64–
65% identity with Bm-CPL-1, -4 and -5) and Bp-CPL-4 (77, 91 and
94% identity with Bm-CPL-1, -5 and -4, respectively) recognized
the reproductive system in B. malayi similarly [39] (S. Lustigman,
unpublished data), and this localization was similar to that of Ce-
CPL-1 [40]. The putative functions of the group Ic cathepsin L-
like protease enzymes (Bm-cpl-2, Bm-cpl-3, Bm-cpl-6, Bm-cpl-7 and
Bm-cpl-8) are still unknown. In C. elegans, Ce-cpl-1 was shown to be
essential for embryogenesis [40], while Ce-cpz-1 has a function
during embryogenesis but is not essential and also has an
important role during molting [44]. The C. elegans Ce-cpl-1
knock-out mutant has an embryonic lethal phenotype [40]. RNAi
targeting of Ce-cpl-1 produced an early embryonic lethal
phenotype with 95–100% of F1 embryos arresting with only
100–200 cells following dsRNA injection and ,92% of F1
embryos arresting after soaking of L4 in dsRNA [40]. Interest-
ingly, the H. contortus cpl-1 gene can rescue the C. elegans cpl-1 RNAi
effect, suggesting that the parasite CPL is an orthologue of C.
elegans CPL-1 and that CPL-1 is functionally conserved in parasitic
nematode species [52]. This is further demonstrated in O. volvulus,
where Ov-cpl-1 can rescue the C. elegans Ce-cpl-1 mutant, using a
rescue construct containing the Ce-cpl-1 promoter, the full length
Ov-cpl-1 cDNA from the first ATG to the stop codon and the
Ce-cpl-1 39UTR (S. Hashmi, unpublished data).
However, despite high sequence similarity the predicted
essential function of a gene is not always essentially conserved in
both filarial nematodes and C. elegans, as has been shown for the
different roles of CPL and CPZ in the molting of O. volvulus and C.
elegans [33]. dsRNA-mediated silencing of the Bm-cpl group Ia
genes in B. malayi adult females leads to phenotypic changes in
embryos, where embryos from Bm-cpl treated worms were not fully
developed within the eggshell, leading to space between the
embryo and eggshell. Embryonic viability following RNAi
treatment with Bm-cpl was also affected.
The role(s) of cysteine proteases during embryo development
have been shown to include an essential role in yolk processing.
Cysteine proteases are known to be involved in yolk degradation
during invertebrate embryonic development [53,54,55] and Ce-
CPL-1 has been shown to play an essential role in yolk protein
processing during embryonic development, where a loss of CPL-1
activity in the Ce-cpl-1 mutant leads to formation of enlarged
cytoplasmic yolk vesicles and embryonic lethality [41]. Whether
the Bm-cpl cysteine proteases are also involved with yolk protein
processing would be interesting to investigate. Immunolocalization
of the native Bm-CPLs indirectly suggests that they do localize to
yolk vesicles within the developing embryonic stages [39] but
further co-localization studies are required to confirm these
observations. Also of relevance would be to investigate the co-
localization of the native Bm-CPLs with their endogenous cysteine
protease inhibitors, such as the cystatins [56]. The activities of
cathepsin-like cysteine proteases are controlled by their specific
endogenous protein inhibitors [57,58]. In C. elegans, co-localization
of CPL-1 and CPZ-1 enzymes with both endogenous CP
inhibitors and yolk proteins has been clearly demonstrated and
data indicates that CPL-1 and CPZ-1 and their putative inhibitor,
Ce-CPI-2a, play a role during oogenesis and fertilization in C.
elegans [59]. The O. volvulus CPL-1 and CPZ are also localized in
the same regions as the endogenous inhibitor, Ov-CPI-2 [40,49],
implying that Ov-CPI-2 may regulate both enzymes during O.
volvulus development. In addition, both enzymes are essential for
third to fourth stage larva molting as demonstrated by RNAi [33].
dsRNA-mediated silencing of the Bm-cpl genes suggests that
some of the B. malayi CPs such as the Bm-CPL group Ia enzymes
may function during embryonic development and show similar
function(s) to C. elegans CPL-1, their most phylogenetically related
CP, therefore suggesting conserved essential function(s) between
these filarial nematode and C. elegans CPs. As CP inhibitors
targeting parasite CPs have been proposed as therapeutics in both
protozoan [60,61,62,63] and metazoan [64,65] parasites, CPs
involved in embryogenesis clearly provide a valuable putative
target if it results in a block in embryogenesis which, in filarial
nematodes, would, in essence, lead to sterility of the adult worm.
Therefore, it would be invaluable to determine specific cysteine
protease inhibitors which would target the endogenous Bm-CPL
group Ia enzymes and moreover, could be used as therapeutic
agents against the parasite. Methodologies, such as synthetic
combinatorial library analysis [66], specific chemical library
screening [67] and small molecule affinity fingerprinting [68] are
available to identify such specific inhibitors.
In order to elucidate the function(s) of the cysteine proteases of
B. malayi we have developed and improved the reverse genetics
RNAi techniques which have been used previously in filarial
nematodes. RNAi has been demonstrated successfully in parasitic
helminths and could provide an invaluable tool in determining
gene function and identification of drug and vaccine targets. Using
RNAi to selectively target the potential drug targets; the cathepsin-
like cysteine protease genes, in adult female B. malayi we have
demonstrated that these genes can be affected; dsRNA-mediated
Figure 6. Soaking B. malayi adult female worms in dsRNA
results in Bm-cpl gene-specific inhibition of expression. At the
end of the experiment (2 d after treatment), groups of four adult female
worms were removed from culture and analyzed for differences in Bm-
cpl gene-specific transcript levels by qRT-PCR. The relative amounts of
Bm-cpl amplicon were determined by using the comparative CT method
and normalizing against the endogenous control gene (Bm-tub-1). The
median value of the control group was set to 100% and the reduction in
expression in the treated groups was calculated as a percentage of the
control. ## denotes a significant difference between dsRNA or siRNA-
treated worms and medium control, while *** denotes a significant
difference between dsRNA or siRNA-treated worms and negative
control (dsRNA of Ov-cpz-Int2) (Mann-Whitney U-test).
doi:10.1371/journal.pntd.0000377.g006
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number of Mf released by adult female nematodes. While Bm-cpl-
1, Bm-cpl-5 and Bm-cpz all showed this persistent phenotype
following dsRNA-mediated silencing the most significant reduc-
tions in the release of Mf were observed with dsRNA
corresponding to Bm-cpl-5 therefore we focused on optimization
of the RNAi technique using fragments corresponding to Bm-cpl-5
and the 100% conserved pro-region of Bm-cpl-1, Bm-cpl-4 and Bm-
cpl-5, designed to target all three of the B. malayi filarial group Ia
cathepsin L-like cysteine protease transcripts [39], which we
named Bm-cpl. Treatment of adult worms with dsRNA or siRNA
corresponding to the Bm-cpl genes resulted in a persistent and
significant reduction in the release of Mf, the majority of which
were dead, and changes in intrauterine progeny. At the same time,
these treatments also resulted in a specific reduction in the Bm-cpl
transcript levels. While we can not directly correlate the observed
phenotypic effects with the specific reduction in Bm-cpl transcript
levels it is tempting to speculate that the effects on embryonic
development and Mf production are due to the specific knock-
down of the Bm-cpl genes using the dsRNA-silencing pathway.
Interestingly, while RNAi treatment using both dsRNA and
siRNA were effective in specific gene silencing, the uptake studies
have suggested that smaller fragments of dsRNA and siRNAs are
able to penetrate adult female B. malayi worms more efficiently
than longer dsRNAs, pointing to the possibility that the cuticle
barrier in the female worm is more yielding to the penetration of
smaller fragments of dsRNA and siRNA. Therefore, the efficiency
of RNAi may be dependent on the dsRNA fragment size. It is also
important to note that due to RNA fragment size differences the
molarity of each dsRNA tested was different (dsRNA range; 400–
800 bp, siRNA; ,13.5 bp, at 1.5 mg/ml; dsRNA range; 2.82–
5.63 mM, siRNA; 166.83 mM, at 2.0 mg/ml; dsRNA range; 3.75–
7.51 mM, siRNA; 222.44 mM). However, despite these molar
differences, RNAi using longer dsRNA was still effective in this in
vitro screening system. dsRNA molarity has been shown to affect
the efficiency of RNAi targeting of actin in L. sigmodontis (Ls-act)
with 3.5 mM giving the most consistent reductions in transcript,
while higher molar concentrations of dsRNA (17.5 and 35 mM)
resulted in increased levels of heat shock protein 60 (Ls-hsp60)
suggesting the worms were stressed [35]. Therefore dsRNA
molarity might still be an important consideration to keep in
mind when optimizing RNAi techniques.
While successful siRNA application has been reported in T.
colubriformis [69] and S. mansoni [70,71] it has not previously been
documented for filarial nematodes. We have shown for the first
time that RNAi treatment using siRNA can also be effective in
filarial nematodes and show the same phenotypic changes and
reduction in transcript levels as RNAi treatment with fragments
corresponding to the same region of dsRNA. This provides an
additional RNAi strategy for future projects aimed at assessing the
function(s) of genes in filarial worms and the discovery of novel
drug targets. This is important as many of the inconsistencies with
RNAi in parasitic helminths could be due to differences in the
RNAi pathways between these helminths and free-living C. elegans.
Analyses of genome databases, including H. contortus [30] and B.
malayi [72], have shown that while putative orthologues of many
genes required for RNAi are present, other genes which are
essential for the recognition and systemic spread of dsRNA in C.
elegans, such as rde-4, sid and rsd genes, appear to be absent. The
absence of these genes could explain the problems associated with
RNAi in parasitic helminths, although it could be that these genes
are not required or alternative pathways exist. However, although
the genes for dsRNA processing appear to be missing, the
machinery for processing siRNA appears to be present. Therefore,
the use of siRNA vs. dsRNA may provide a more robust RNAi
assay for some of the target transcripts.
We have also tested an alternative method for delivering the
dsRNA molecules to adult B. malayi, which are notoriously difficult
to maintain in culture for extended periods [73], by culturing
worms in dialysis tubes in the presence of dsRNA. This technique
provides a way of minimizing the handling of nematodes and has
the potential to facilitate higher-throughput RNAi screens. Dialysis
of the dsRNA prior to RNAi treatment was also important in
reducing the non-specific off-target effects which can occur
following RNAi [74]. In filarial parasites treatment with control
dsRNA, resulted in a 24.7–49.8% reduction in molting of O.
volvulus L3 larvae [32,33], and resulted in reduced motility in B.
malayi adult worms [34]. Off-target effects following RNAi
treatment have also been demonstrated in S. mansoni, these
including non-specific changes in mRNA levels, changes in
cercariae distribution and reduction in sporocyst length following
treatment with control dsRNA [75,76]. We noted some non-
specific toxic effects of unrelated dsRNA; for example the RNAi
with the negative control dsRNA we selected to use, Ov-cpz-int2,
resulted in 14.9% reduction in the release of Mf 48 h after RNAi.
However, this was not accompanied by any indirect knock-down
in target gene transcription. E. coli b-lactamase (Ec-bla) dsRNA
(GenBank accession no. NC_010862, position 24517-24770) [43]
was also used as a negative control and also showed some off target
effects (1.8%, 10.5% and 26.0% reduction in Mf release on day 1,
3 and 5). Regardless, the effect with the gene specific RNAi was
significant. These off-target effects could, in part, be due to an
innate immune response mounted in the nematode in response to
foreign RNA. Viral RNAs are recognized by the innate immune
response through toll-like receptor (TLR) 3 for dsRNA and TLR7
or TLR8 for ssRNA [77]. In addition, RNA silencing serves as an
innate anti-viral mechanism in plants, fungi and animals [78,79],
and has been shown to be involved in C. elegans [80]. RNAi
silencing in nematodes may have evolved to protect them against
viruses and it could be speculated as a reason to why nematodes
appear to be free from viruses. Another possibility is that the off-
target effects could be due to the generation of microRNAs
(miRNAs) from the dsRNA control sequence used. Intronic
sequences have been shown to potentially also contain functional
miRNAs [81,82]. However, searching the intron sequence used in
this study (Ov-cpz-int2) shows that it contains no miRNA regions so
this appears unlikely.
In order to effectively assess the essential function(s) of filarial
genes using RNAi it is important to keep in mind the
unpredictability associated with RNAi and to take care to optimize
the conditions according to the target gene of interest. Suppression
of gene expression following RNAi treatment, using current
methodologies, appears to be more effective for some genes rather
than others [83,84]. This could be due to experimental parameters
such as dsRNA preparations, length of dsRNA, and regions of
dsRNA amplified, or parasite factors including abundance and
location of the target gene transcript. As seen in C. elegans the life-
cycle stage may also be important; RNAi is often not efficient in
the treated worms (P0), and the phenotypic effects are only obvious
in the progeny (F1), after the target mRNA that is produced in the
F1 generation is also degraded [85]. Our studies, unfortunately,
can only measure the phenotypic and genotypic outcomes in
treated (P0) adult female worms. When the steady-state transcript
levels in the adult worms are high it can be difficult to observe
significant reduction even though the phenotypic release of F1
progeny is affected. One potential solution will be, in the future, to
also measure the transcript levels of the targeted mRNA in the F1
progeny within the uterus or secreted into culture. In order to be
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culture conditions in parasitic nematodes need to be optimized in
order to maintain parasites for longer periods of time and, ideally,
to allow for their subsequent development into the next life-cycle
stages. The effects of RNAi treatment may also need to be studied
directly in vivo or after monitoring the development of the F1
following treatment of adult worms in vitro then passing the
secreted Mf through the full life-cycle in vivo. It may also be
possible to perform RNAi directly on early developmental stages
such as eggs and embryos. Using uptake studies we can
demonstrate that dsRNA is taken up into eggs and embryos
isolated from the uterine contents of adult female B. malayi (L.
Ford&S. Lustigman, unpublished data).
In order to maximally utilize RNAi in parasitic helminths as a
tool for determining gene function and for high-throughput
screening of potential drug and vaccine candidates, various
problems need to be addressed and optimization of both the
long-term culturing conditions and RNAi techniques is required.
By modifying both ours and published RNAi techniques we have
shown persistent dsRNA-mediated silencing and demonstrated
improved RNAi techniques.
In conclusion, RNAi assays have allowed us to examine the
function(s) of the cathepsin-like cysteine protease filarial group Ia
genes in B. malayi adult female worms and have demonstrated that
they have function(s) in embryogenesis and development which are
similar to their orthologous genes in C. elegans. Thus, validating the
potential of the filarial cysteine proteases as promising drug targets
for filarial chemotherapy.
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